Abstract: A composition for an aqueous emulsion polymerization which comprises at least one derivatized alkyl polyglucoside surfactant in a range of 0.01-10%; water, in a range from 20-80% by weight; at least one monomer for emulsion polymerization making up 20-80% of the emulsion polymerization, and at least one initiator in the range of 0.01-5%; with the derivatized alkylpolyglucosides being polyoxyethylene, ethylene oxide and 1,4-dioxane free.

Abstract: A system includes a hydraulic energy transfer system configured to exchange pressures between a first fluid and a second fluid. The system also includes a motor system configured to power the hydraulic energy transfer system and a shaft coupling the motor system and the hydraulic energy transfer system. Additionally, the system includes a shaft seal disposed about the shaft. Further, the system includes a pressure compensator configured to reduce a pressure differential across the shaft seal.

Abstract: A system includes a hydraulic energy transfer system configured to exchange pressures between a first fluid and a second fluid. The system also includes a motor system configured to power the hydraulic energy transfer system and a shaft coupling the motor system and the hydraulic energy transfer system. Additionally, the system includes a shaft seal disposed about the shaft. Further, the system includes a pressure compensator configured to reduce a pressure differential across the shaft seal.

Abstract: This invention relates to: (a) compounds of formula I and salts thereof that, inter alia, are useful as hepatitis C virus (HCV) inhibitors; (b) intermediates useful for the preparation of such compounds and salts; (c) pharmaceutical compositions comprising such compounds and salts; and (d) methods of use of such compounds, salts, and compositions.

Abstract: This invention relates to: (a) compounds of formula I and salts thereof that, inter alia, are useful as hepatitis C virus (HCV) inhibitors; (b) intermediates useful for the preparation of such compounds and salts; (c) pharmaceutical compositions comprising such compounds and salts; and (d) methods of use of such compounds, salts, and compositions.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Bacterial protein synthesis-inhibiting compounds having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods of using the compounds are disclosed.

Abstract: This invention relates to: (a) compounds of formula I and salts thereof that, inter alia, are useful as hepatitis C virus (HCV) inhibitors; (b) intermediates useful for the preparation of such compounds and salts; (c) pharmaceutical compositions comprising such compounds and salts; and (d) methods of use of such compounds, salts, and compositions.

Abstract: A method and apparatus are provided for detecting a connection associated with a display and a system having a first and second video output port. Data channel information associated with the first video output port and the second video output port are read using DDC instructions and the absence of a connection between the display and the first video output port is detected. Information associated with the absence of the connection is transferred to the display which is connected to the second video output port such that the transferred information associated with the absence of the connection can be displayed to a user in the form of an error message.

Abstract: Bacterial protein synthesis-inhibiting compounds having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods of using the compounds are disclosed.

Abstract: A method and apparatus are provided for detecting a connection associated with a display and a system having a first and second video output port. Data channel information associated with the first video output port and the second video output port are read using DDC instructions and the absence of a connection between the display and the first video output port is detected. Information associated with the absence of the connection is transferred to the display which is connected to the second video output port such that the transferred information associated with the absence of the connection can be displayed to a user in the form of an error message.

Abstract: Compounds having formula (I) 1